此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Impact of Physical Activity During Pregnancy on Biological Markers at Birth in Cord Blood (CORDOMOUV) (CORDOMOUV)

2026年6月18日 更新者:University Hospital, Clermont-Ferrand

Currently, an interventional protocol for physical activity during pregnancy is underway at the Clermont University Hospital (PREGMOUV study). In addition, we have implemented a protocol for 2 years monitoring of children birthed of this study (NEOMOUV study).

Recent data from the scientific literature show that a woman's engagement in regular and appropriate physical activity during her pregnancy presents few dangers while ensuring benefits for the mother-baby dyad. Indeed, physical activity reduces maternal complications such as preeclampsia, gestational diabetes and depression and has many advantages for the child with in particular a reduction in the risk of macrosomia then obesity and diabetes.

Neonatal sepsis is a major risk factor for childhood mortality. There is strong negative association between cord blood levels of calprotectin and sepsis risk in human newborns with levels of calprotectin at birth are significantly lower in infants that later experience blood-culture-proven late-onset neonatal sepsis. In adults, plasma calprotectin levels increase following acute exercise. However after 4 weeks trainging plasma calprotectin level decrease. So in response to acute exercise, plasma calprotectin levels increase but in contrast, there is a negative association between basal plasma calprotectin levels and regular physical activity. Therefore, we do not know what impact mother' regular physical activity can have on the level of calprotectin in the cord blood.

The objective of this project is to investigate the impact of physical activity during pregnancy on calprotectin value at cord blood.

研究概览

研究类型

观察性的

注册 (估计的)

250

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子

接受健康志愿者

是的

取样方法

非概率样本

研究人群

Newborns born to mothers who participated in the PregMouv study

描述

Inclusion Criteria:

  • Newborns born to mothers who participated in the PregMouv study (which aims to evaluate an intervention allowing women to better adhere to physical activity: program free/face-to-face/videoconference/mixed) and born at the Clermont Ferrand University Hospital.

Exclusion Criteria:

  • If parents refuse to participate or in situations where parents are protected by law, cord blood collection cannot be done.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
cord blood
Total physical activity time (in MET minutes/week) of pregnant women measured at Trimestry 3 (explanatory variable)

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Calprotectin levels
大体时间:at birth
Calprotectin levels (ng/mL), collected from cord blood immediately after birth according to Total physical activity time (in MET minutes/week) of pregnant women measured at Trimestry 3
at birth

次要结果测量

结果测量
措施说明
大体时间
calprotectin level
大体时间:at birth
Calprotectin levels (ng/mL) in umbilical cord blood at birth according to delivery mode
at birth
calprotectin level
大体时间:at birth
Calprotectin levels (ng/mL) in umbilical cord blood at birth according to maternal physical activity levels during pregnancy at T2
at birth
calprotectin level
大体时间:at birth
Calprotectin levels (ng/mL) in umbilical cord blood at birth according to gestational age at birth
at birth
calprotectin level
大体时间:at birth
Calprotectin levels (ng/mL) in umbilical cord blood at birth according to sedentary lifestyle levels at T2 and T3
at birth
calprotectin level
大体时间:at birth
Calprotectin levels (ng/mL) in umbilical cord blood at birth according to maternal body composition (kg/m²)
at birth
transcriptomic
大体时间:at birth
mRNA expression level in umbilical cord blood at birth according to maternal body composition (kg/m²)
at birth
transciptomic
大体时间:at birth
mRNA expression level in umbilical cord blood at birth according to delivery mode
at birth
transciptomic
大体时间:at birth
mRNA expression level in umbilical cord blood at birth according to maternal physical activity levels during pregnancy at T2
at birth
transciptomic
大体时间:at birth
mRNA expression level in umbilical cord blood at birth according to gestational age at birth
at birth
transciptomic
大体时间:at birth
mRNA expression level in umbilical cord blood at birth according to sedentary lifestyle levels at T2 and T3
at birth
transciptomic
大体时间:at birth
mRNA expression level in umbilical cord blood at birth according to maternal body composition (kg/m²)
at birth

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Solène FEL、University Hospital, Clermont-Ferrand

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年5月5日

初级完成 (估计的)

2027年10月1日

研究完成 (估计的)

2027年10月1日

研究注册日期

首次提交

2026年4月24日

首先提交符合 QC 标准的

2026年5月4日

首次发布 (实际的)

2026年5月12日

研究记录更新

最后更新发布 (实际的)

2026年6月22日

上次提交的符合 QC 标准的更新

2026年6月18日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

其他研究编号

  • RNI 2026 FEL
  • 2026-A00010-51 (其他标识符:ANSM)

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅